Stock Events

Stock Events

Maravai LifeSciences 

$5.74
47
+$0.06+1.06% Tuesday 20:00
+$0.00+0%Tuesday 20:10After hours

Statistics

Day High
5.75
Day Low
5.74
52W High
7.44
52W Low
2.28
Volume
47,397
Avg. Volume
-
Mkt Cap
855.2M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

5NovExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
-0.08
-0.05
-0.02
0.01
Expected EPS
-0.053059
Actual EPS
N/A

Financials

-70.41%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
185.74MRevenue
-130.77MNet Income

Analyst Ratings

6.50Average Price Target
The highest estimate is 6.50.
From 1 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow MRVI. It's not an investment recommendation.
Amazon
8
AMZN
Apple
7
AAPL
Tesla
7
TSLA
Altria Group
7
MO

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Illumina
ILMN
Mkt Cap28.82B
Illumina provides sequencing and array-based solutions for genetic analysis, directly competing in the genomics and life sciences market that Maravai serves.
Thermo Fisher Scientific
TMO
Mkt Cap217.52B
Thermo Fisher Scientific offers a broad range of reagents, instruments, and consumables used in biotechnology and pharmaceutical research, overlapping with Maravai's product offerings.
Qiagen NV
QGEN
Mkt Cap8.87B
Qiagen is a provider of sample and assay technologies for molecular diagnostics, applied testing, academic and pharmaceutical research, competing in similar segments as Maravai.
Bio-Rad Laboratories
BIO
Mkt Cap9.53B
Bio-Rad Laboratories manufactures and supplies products and systems used for gene expression, protein purification, and analysis, which are areas Maravai also operates in.
Pacific Biosciences of California
PACB
Mkt Cap357.46M
Pacific Biosciences offers sequencing systems that compete with Maravai's nucleic acid production and services for the genomics industry.
Abbott Laboratories
ABT
Mkt Cap192.51B
Abbott Laboratories, through its diagnostics and medical devices, competes in the broader life sciences sector, impacting Maravai's market space.
Danaher
DHR
Mkt Cap142.32B
Danaher Corporation's life sciences segment provides a range of research and clinical tools that directly compete with Maravai's offerings.
Agilent Technologies
A
Mkt Cap41.95B
Agilent Technologies provides instruments, services, consumables, applications, and expertise, serving the same life sciences and applied chemical markets as Maravai.
Repligen
RGEN
Mkt Cap9.42B
Repligen Corporation supplies bioprocessing technologies and systems that are used in the production of biologic drugs, competing with Maravai's biotech and pharmaceutical services.
Guardant Health
GH
Mkt Cap21.1B
Guardant Health focuses on liquid biopsies and cancer diagnostics, competing in the precision medicine and diagnostics segment that Maravai is also targeting.

About

Maravai LifeSciences Holdings Inc is a life sciences company providing products and services to enable the development of drugs, therapeutics, vaccines and diagnostics, and to support research on human disease. Its product portfolio includes complex nucleic acids, custom enzymes and antibody-based solutions for therapeutic, vaccine, diagnostic and biopharmaceutical production applications. The Company operates through two segments: TriLink, which generates maximum revenue from North America and provides nucleic acid products and services including mRNA, oligonucleotides and related technologies; and Cygnus, which provides biologics safety testing products and services including host cell protein ELISA kits, impurity detection assays and related reagents and services.
Show more...
CEO
Bernd Brust
Employees
416
Country
United States
ISIN
US56600D1072
WKN
000A2QHK8

Listings

STU
DE
MAR.STU
F
DE
MAR.F
MX
MX
MRVI.MX
BOATS
BOATS
MRVI.BOATS

0 Comments

Share your thoughts

FAQ

What is Maravai LifeSciences stock price today?▼
The current price of MRVI is $5.74 USD — it has increased by +1.06% in the past 24 hours. Watch Maravai LifeSciences stock price performance more closely on the chart.
What is Maravai LifeSciences stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Maravai LifeSciences stocks are traded under the ticker MRVI.
Is Maravai LifeSciences stock price growing?▼
MRVI stock has fallen by -0.69% compared to the previous week, the month change is a -20.72% fall, over the last year Maravai LifeSciences has showed a +128.69% increase.
What is Maravai LifeSciences market cap?▼
Today Maravai LifeSciences has the market capitalization of 855.2M
When is the next Maravai LifeSciences earnings date?▼
Maravai LifeSciences is going to release the next earnings report on November 05, 2026.
What were Maravai LifeSciences earnings last quarter?▼
MRVI earnings for the last quarter are -0.02 USD per share, whereas the estimation was -0.04 USD resulting in a +54.05% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Maravai LifeSciences revenue for the last year?▼
Maravai LifeSciences revenue for the last year amounts to 185.74M USD.
What is Maravai LifeSciences net income for the last year?▼
MRVI net income for the last year is -130.77M USD.
How many employees does Maravai LifeSciences have?▼
As of August 19, 2026, the company has 416 employees.
In which sector is Maravai LifeSciences located?▼
Maravai LifeSciences operates in the Health & Wellness sector.
When did Maravai LifeSciences complete a stock split?▼
Maravai LifeSciences has not had any recent stock splits.
Where is Maravai LifeSciences headquartered?▼
Maravai LifeSciences is headquartered in SAN DIEGO, United States.